Hugo Donaldson

1.3k total citations · 1 hit paper
24 papers, 873 citations indexed

About

Hugo Donaldson is a scholar working on Epidemiology, Molecular Medicine and Endocrinology. According to data from OpenAlex, Hugo Donaldson has authored 24 papers receiving a total of 873 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 9 papers in Molecular Medicine and 6 papers in Endocrinology. Recurrent topics in Hugo Donaldson's work include Antibiotic Resistance in Bacteria (9 papers), Antibiotic Use and Resistance (6 papers) and Bacterial Identification and Susceptibility Testing (3 papers). Hugo Donaldson is often cited by papers focused on Antibiotic Resistance in Bacteria (9 papers), Antibiotic Use and Resistance (6 papers) and Bacterial Identification and Susceptibility Testing (3 papers). Hugo Donaldson collaborates with scholars based in United Kingdom and United States. Hugo Donaldson's co-authors include Luke Moore, Stephen Hughes, Oliver Troise, Nabeela Mughal, Alison Holmes, Jane F. Turton, Mark Gilchrist, Rachel Freeman, Annette Jepson and William Cookson and has published in prestigious journals such as PLoS ONE, Scientific Reports and Journal of Neurology Neurosurgery & Psychiatry.

In The Last Decade

Hugo Donaldson

22 papers receiving 846 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting

2020 452 citations Stephen Hughes, Oliver Troise et al. Clinical Microbiology and Infection profile →

Peers

Countries citing papers authored by Hugo Donaldson

Since Specialization

Citations

This map shows the geographic impact of Hugo Donaldson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hugo Donaldson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hugo Donaldson more than expected).

Fields of papers citing papers by Hugo Donaldson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hugo Donaldson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hugo Donaldson. The network helps show where Hugo Donaldson may publish in the future.

Co-authorship network of co-authors of Hugo Donaldson

This figure shows the co-authorship network connecting the top 25 collaborators of Hugo Donaldson. A scholar is included among the top collaborators of Hugo Donaldson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hugo Donaldson. Hugo Donaldson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Investigating the cause of increased tetracycline-resistant Neisseria gonorrhoeae in England, 2016–20 2024 ·Journal of Antimicrobial Chemotherapy ·Rachel Pitt, (unknown), Stephen Hughes, (unknown), Hugo Donaldson, Michael Rayment, (unknown), Michaela Day, (unknown), Monica Rebec, (unknown), Hamish Mohammed, Katy Sinka, Michelle Cole, Helen Fifer	2
2	A practical laboratory method to determine ceftazidime-avibactam-aztreonam synergy in patients with New Delhi metallo-beta-lactamase (NDM)–producing Enterobacterales infection 2022 ·Journal of Global Antimicrobial Resistance ·Timothy M. Rawson, (unknown), (unknown), (unknown), Mark Gilchrist, (unknown), Luke Moore, Hugo Donaldson, Frances Davies	17
3	A prospective surveillance study to determine the prevalence of 16S rRNA methyltransferase-producing Gram-negative bacteria in the UK 2021 ·Journal of Antimicrobial Chemotherapy ·Emma Taylor, Abhijit M. Bal, Indran Balakrishnan, Nicholas M. Brown, Phillipa Burns, (unknown), Mathew Diggle, Hugo Donaldson, Ian Eltringham, Jonathan Folb, Naomi J. Gadsby, Mairi Macleod, (unknown), Cheryl Williams, Mandy Wootton, Shiranee Sriskandan, Neil Woodford, Katie L. Hopkins	11
4	Association between SARS-CoV-2 exposure and antibody status among healthcare workers in two London hospitals: a cross-sectional study 2021 ·Infection Prevention in Practice ·(unknown), Rachael Jones, Michael Rayment, Nabeela Mughal, B S Azadian, Hugo Donaldson, Gary Davies, Luke Moore, Alexander M. Aiken	0
5	A case of Extensively Drug Resistant (XDR) Extended Spectrum Beta-Lactamase (ESBL) typhoid fever in the Ambulatory Emergency Care (AEC) unit 2021 ·Clinical Infection in Practice ·(unknown), (unknown), Oliver Troise, Stephen Hughes, Hugo Donaldson, (unknown)	1
6	Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting breakdown → 2020 ·Clinical Microbiology and Infection ·Stephen Hughes, Oliver Troise, Hugo Donaldson, Nabeela Mughal, Luke Moore	452
7	Surveillance for Azole-Resistant Aspergillus fumigatus in a Centralized Diagnostic Mycology Service, London, United Kingdom, 1998–2017 2018 ·Frontiers in Microbiology ·Alireza Abdolrasouli, Michael A. Petrou, (unknown), Johanna Rhodes, Timothy M. Rawson, Luke Moore, Hugo Donaldson, Alison Holmes, Matthew C. Fisher, Darius Armstrong‐James	24
8	Emergence and clonal spread of colistin resistance due to multiple mutational mechanisms in carbapenemase-producing Klebsiella pneumoniae in London 2017 ·Scientific Reports ·Jonathan A. Otter, Michel Doumith, Frances Davies, Siddharth Mookerjee, (unknown), Mark Gilchrist, Eimear Brannigan, Kathleen B. Bamford, (unknown), Hugo Donaldson, David M. Aanensen, Matthew J. Ellington, Robert L. Hill, Jane F. Turton, Katie L. Hopkins, Neil Woodford, Alison Holmes	47
9	A clinical approach to managing Pseudomonas aeruginosa infections 2016 ·British Journal of Hospital Medicine ·Luke Moore, Joel Cunningham, Hugo Donaldson	11
10	Improving the care of patients with severe open fractures of the tibia 2016 ·The Bone & Joint Journal ·(unknown), Graham Lawton, Dinesh Nathwani, Michael Pearse, S. Naique, Anthony J. Dodds, Hugo Donaldson, Rajarshi Bhattacharya, Abhilash Jain, Jonathan Simmons, Shehan Hettiaratchy	50
11	Characterization of lytic bacteriophages of Klebsiella pneumoniae with capsular depolymerases 2016 ·Spiral (Imperial College London) ·(unknown), (unknown), (unknown), Hugo Donaldson, (unknown), (unknown), Anatoliy Markiv, A.L. McCartney, Lesley Hoyles	1
12	WaterborneElizabethkingia meningosepticain Adult Critical Care1 2015 ·Emerging infectious diseases ·Luke Moore, (unknown), Annette Jepson, Jane F. Turton, (unknown), Hugo Donaldson, Alison Holmes	58
13	Late-Onset Bloodstream Infection and Perturbed Maturation of the Gastrointestinal Microbiota in Premature Infants 2015 ·PLoS ONE ·Alex Shaw, Kathleen Sim, Paul Randell, Michael J. Cox, (unknown), Mingshi Li, Hugo Donaldson, Paul R. Langford, William Cookson, Miriam F. Moffatt, J. Simon Kroll	78
14	Homogeneity of antimicrobial policy, yet heterogeneity of antimicrobial resistance: antimicrobial non-susceptibility among 108 717 clinical isolates from primary, secondary and tertiary care patients in London 2014 ·Journal of Antimicrobial Chemotherapy ·Luke Moore, Rachel Freeman, Mark Gilchrist, Myriam Gharbi, Eimear Brannigan, Hugo Donaldson, David M. Livermore, Alison Holmes	34
15	Lessons for Control of Heroin-Associated Anthrax in Europe from 2009–2010 Outbreak Case Studies, London, UK 2014 ·Emerging infectious diseases ·Aula Abbara, Tim Brooks, Graham P. Taylor, (unknown), Hugo Donaldson, (unknown), Alison Holmes	16
16	Investigating Clostridium difficile 2013 ·British Journal of Hospital Medicine ·Luke Moore, Hugo Donaldson	1
17	Using infection specialists 2012 ·British Journal of Hospital Medicine ·Luke Moore, James Hatcher, Hugo Donaldson	1
18	Multiple intracranial abscesses due toStreptococcus anginosusin a previously well individual 2012 ·Journal of Neurology Neurosurgery & Psychiatry ·Matthew A. Kirkman, Hugo Donaldson, Kevin O’Neill	3
19	Evaluation of the VITEK(R)2 AST N-054 test card for the detection of extended-spectrum -lactamase production in Escherichia coli with CTX-M phenotypes 2008 ·Journal of Antimicrobial Chemotherapy ·Hugo Donaldson, (unknown), David M. Livermore, Paul J. Rooney, Grace Ong, (unknown), Richard D. Campbell, Ronan McMullan	7
20	Acute transplant rejection induced by blood transfusion reaction to the Kidd blood group system 2004 ·Nephrology Dialysis Transplantation ·S. Holt, Hugo Donaldson, G. R. Hazlehurst, Z. Varghese, (unknown), Edward Kingdon, P. Sweny, A. Burns	23

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact